Pfizer Inc.

NYSE:PFE   3:59:59 PM EDT
44.12
+0.36 (+0.82%)
Products

Pfizer And Biontech Submit Application To FDA For Emergency Use Authorization Of Omicron Ba.4/Ba.5-Adapted Bivalent Covid-19 Vaccine

Published: 08/22/2022 14:42 GMT
Pfizer Inc. (PFE) - Pfizer - Rolling Submission for Omicron Ba.
4/ba.
5-adapted Bivalent Vaccine to Be Completed With the European Medicines Agency in the Coming Days.
Pfizer and Biontech Submit Application to U.S. FDA for Emergency Use Authorization of Omicron Ba.
4/ba.
5-adapted Bivalent Covid-19 Vaccine.
Further Company Coverage: [22uay.
De].
((reuters.
Briefs@thomsonreuters.
Com;)).